Suppr超能文献

冠状动脉或血管介入术后的对比剂肾病:生物标志物众多但仍无答案。

Contrast induced nephropathy after coronary or vascular intervention: More biomarkers than answers.

作者信息

Annamalai Shiva K, Kapur Navin K

机构信息

The CardioVascular Center, Tufts Medical Center, Boston, Massachusetts.

出版信息

Catheter Cardiovasc Interv. 2018 Jun;91(7):1192-1193. doi: 10.1002/ccd.27671.

Abstract

Rising urine NGAL and serum creatinine after 48 hr are potentially useful in predicting persistent creatinine increase in patients with contrast-induced AKI. Urinary NGAL may allow for early identification of a high-risk cohort following PCI. Future studies are needed to determine whether renal biomarkers are affected by clinical variables, such as heart failure acute mechanical circulatory support (AMCS) and whether they can be used to identify patients who would benefit from either AMCS reno-protection during PCI remains unknown.

摘要

48小时后尿中性粒细胞明胶酶相关脂质运载蛋白(NGAL)和血清肌酐升高可能有助于预测造影剂所致急性肾损伤(AKI)患者的肌酐持续升高。尿NGAL可能有助于早期识别PCI术后的高危人群。未来需要开展研究以确定肾脏生物标志物是否受临床变量(如心力衰竭、急性机械循环支持(AMCS))的影响,以及它们是否可用于识别在PCI期间能从AMCS肾脏保护中获益的患者,目前这些仍不清楚。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验